Chemo-proof T cells
Incysus's chemo-resistant γδ T cells could treat solid tumors
T cell therapies have shown unprecedented efficacy in hematologic malignancies, but haven’t produced the same results in solid tumors and have dangerous toxicities. By combining engineered, drug-resistant γδ T cells with chemotherapy, Incysus Ltd. has hit upon a strategy that may be safer and more effective against solid tumors than conventional T cell therapies.
The αβ T cells most T cell therapies use are antigen-specific and may not eliminate the